Loading…
Dong-A Pharmaceutical signed an exclusive domestic supply agreement with Neuain on June 13, 2023, for a migraine relief medical device. The wearable device, which received FDA 510K and CE-MDD certification, will be exclusively sold by Dong-A in South Korea.